NSPR vs. BFLY, DCTH, RXST, SNWV, NPCE, SMTI, CLPT, TCMD, BWAY, and DRTS
Should you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include Butterfly Network (BFLY), Delcath Systems (DCTH), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Sanara MedTech (SMTI), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Brainsway (BWAY), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.
InspireMD vs. Its Competitors
InspireMD (NYSE:NSPR) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.
44.8% of InspireMD shares are held by institutional investors. Comparatively, 37.9% of Butterfly Network shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 25.2% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
InspireMD has higher earnings, but lower revenue than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.
InspireMD currently has a consensus price target of $4.50, indicating a potential upside of 85.95%. Butterfly Network has a consensus price target of $3.00, indicating a potential upside of 92.93%. Given Butterfly Network's higher probable upside, analysts clearly believe Butterfly Network is more favorable than InspireMD.
In the previous week, Butterfly Network had 3 more articles in the media than InspireMD. MarketBeat recorded 5 mentions for Butterfly Network and 2 mentions for InspireMD. Butterfly Network's average media sentiment score of 0.97 beat InspireMD's score of 0.84 indicating that Butterfly Network is being referred to more favorably in the news media.
InspireMD has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.52, suggesting that its share price is 152% more volatile than the S&P 500.
Butterfly Network has a net margin of -71.79% compared to InspireMD's net margin of -413.96%. Butterfly Network's return on equity of -30.53% beat InspireMD's return on equity.
Summary
Butterfly Network beats InspireMD on 10 of the 16 factors compared between the two stocks.
Get InspireMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
InspireMD Competitors List
Related Companies and Tools
This page (NYSE:NSPR) was last updated on 9/6/2025 by MarketBeat.com Staff
Free NSPR Stock Alerts